Delivery Order SPE2DR25D2014-SPE2DR26FA3C8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,033.47 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with performance scheduled for completion by August 18, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a $4,331.62 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract has a firm fixed price structure and is scheduled for completion by June 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,110.06 to supply Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of December 17, 2025. The award was made on December 16, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,994.33 delivery order for Lantus SoloStar 100 Unit/ML 3ML insulin pens, with a completion date of December 23, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,999.74 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This competitively awarded, non-set-aside contract was executed on December 18, 2025, with an ultimate completion date of December 19, 2025. The contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a $2,128.57 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive...
- The Defense Logistics Agency awarded a $8,990.27 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a completion date of January 8, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,399.51 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract features firm fixed pricing and is scheduled for completion by April 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,238.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a completion date of June 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,310.67 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside, competitively awarded contract operates under a firm fixed-price model with an ultimate completion date of December 2, 2025. The award was issued on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA3C8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,051.98 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was awarded on January 21, 2026, with an ultimate completion date of January 22, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026 that enables AmerisourceBergen to supply a vast range of pharmaceuticals and medical supplies supporting military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs across the Department of Defense and related healthcare systems. The company holds significant contracts with the Defense Logistics Agency and was selected as a single-award IDC holder for pharmaceutical supply, positioning it as a key vendor for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. All of the company's federal contract awards reviewed are competitively awarded and non-set-aside, demonstrating its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 1/20/26 |